TENAX THERAPEUTICS, INC.: 10-K filed 2017-03-16

Name: TENAX THERAPEUTICS, INC.: 10-K filed 2017-03-16
Creator: TENAX THERAPEUTICS, INC.

What TENAX THERAPEUTICS, INC. reported in its annual report filed 2017-03-16 (fiscal FY 2016): 40 published measures, 127 facts as tagged in accession 0001654954-17-002098.

This filing

Form: 10-K (annual report)
Filed: 2017-03-16
Fiscal period: fiscal FY 2016
Accession: 0001654954-17-002098 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All TENAX THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2016-12-31	23,340,175	USD
At 2015-12-31	72,987,078	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2016-12-31	6,199,237	USD
At 2015-12-31	12,563,730	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2016-12-31	17,140,938	USD
At 2015-12-31	60,423,348	USD
At 2015-04-30	70,429,034	USD
At 2014-04-30	82,855,361	USD
At 2013-04-30	-1,778,036	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2016-12-31	9,995,955	USD
At 2015-12-31	3,660,453	USD
At 2015-04-30	7,926,491	USD
At 2014-04-30	58,320,555	USD
At 2013-04-30	783,528	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	-43,923,904	USD	366
2015-05-01 to 2015-12-31	-10,067,964	USD	245
2014-05-01 to 2015-04-30	-14,081,812	USD	365
2013-05-01 to 2014-04-30	-19,541,839	USD	365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	-15,871,300	USD	366
2015-05-01 to 2015-12-31	-8,950,610	USD	245
2014-05-01 to 2015-04-30	-9,748,794	USD	365
2013-05-01 to 2014-04-30	-9,261,571	USD	365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	2,884	USD	366
2015-05-01 to 2015-12-31	16,688	USD	245
2014-05-01 to 2015-04-30	4,234	USD	365
2013-05-01 to 2014-04-30	9,804	USD	365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	0	USD	366
2015-05-01 to 2015-12-31	0	USD	245
2014-05-01 to 2015-04-30	49,286	USD	365
2013-05-01 to 2014-04-30	158,926	USD	365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	0	USD	366
2015-05-01 to 2015-12-31	-100,160	USD	245
2014-05-01 to 2015-04-30	280,590	USD	365
2013-05-01 to 2014-04-30	66,945,636	USD	365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	22,206,802	USD	366
2015-05-01 to 2015-12-31	4,784,732	USD	245
2014-05-01 to 2015-04-30	-40,925,860	USD	365
2013-05-01 to 2014-04-30	-147,038	USD	365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2016-12-31	-204,659,603	USD
At 2015-12-31	-160,735,699	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	-7,962,100	USD	366
2015-05-01 to 2015-12-31	0	USD	245
2015-01-01 to 2015-12-31	0	USD	365
2014-05-01 to 2015-04-30	0	USD	365
2013-05-01 to 2014-04-30	0	USD	365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2016-12-31	19,105	USD
At 2015-12-31	35,786	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	1,062	USD	366
2015-05-01 to 2015-12-31	703	USD	245
2014-05-01 to 2015-04-30	117,295	USD	365
2013-05-01 to 2014-04-30	651,460	USD	365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	-52,650,739	USD	366
2015-05-01 to 2015-12-31	-10,425,498	USD	245
2014-05-01 to 2015-04-30	-14,816,743	USD	365
2013-05-01 to 2014-04-30	-16,611,120	USD	365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2016-12-31	13,628,175	USD
At 2015-12-31	20,560,353	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	0	USD	366
2015-05-01 to 2015-12-31	1,507	USD	245
2014-05-01 to 2015-04-30	49,081	USD	365
2013-05-01 to 2014-04-30	2,212,283	USD	365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2016-12-31	6,199,237	USD
At 2015-12-31	4,601,630	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2016-12-31	727,599	USD
At 2015-12-31	972,483	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2016-12-31	0	USD
At 2015-12-31	11,265,100	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2016-12-31	0	USD
At 2015-12-31	0	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2016-12-31	72,599	USD
At 2015-12-31	49,448	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	52,650,739	USD	366
2015-05-01 to 2015-12-31	10,425,498	USD	245
2014-05-01 to 2015-04-30	14,866,029	USD	365
2013-05-01 to 2014-04-30	16,770,046	USD	365

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	0	USD	366
2015-05-01 to 2015-12-31	0	USD	245
2014-05-01 to 2015-04-30	0	USD	365
2013-05-01 to 2014-04-30	-104,069	USD	365

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	6,245,958	USD	366
2015-05-01 to 2015-12-31	3,940,631	USD	245
2014-05-01 to 2015-04-30	7,170,779	USD	365
2013-05-01 to 2014-04-30	13,773,325	USD	365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	13,139,681	USD	366
2015-05-01 to 2015-12-31	6,484,867	USD	245
2014-05-01 to 2015-04-30	6,660,387	USD	365
2013-05-01 to 2014-04-30	2,996,721	USD	365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2016-12-31	28,120,021	shares
At 2015-12-31	28,119,694	shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2016-12-31	-18,718	USD
At 2015-12-31	-129,442	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2016-12-31	586,730	USD
At 2015-12-31	784,390	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2016-12-31	567,625	USD
At 2015-12-31	748,604	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2016-12-31	0	USD
At 2015-12-31	22,000,000	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2016-12-31	1,106,785	USD
At 2015-12-31	1,106,785	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2016-12-31	5,245,546	USD
At 2015-12-31	3,104,807	USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

Period	Value	Unit	Days
At 2016-12-31	56,180	USD
At 2015-12-31	19,151	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	43,813,180	USD	366
2015-05-01 to 2015-12-31	10,224,124	USD	245
2014-05-01 to 2015-04-30	14,055,094	USD	365
2013-05-01 to 2014-04-30	19,541,839	USD	365

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	43,923,904	USD	366
2015-05-01 to 2015-12-31	10,067,964	USD	245
2014-05-01 to 2015-04-30	14,081,812	USD	365
2013-05-01 to 2014-04-30	25,345,201	USD	365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	18,952	USD	366
2015-05-01 to 2015-12-31	31,224	USD	245
2014-05-01 to 2015-04-30	77,836	USD	365
2013-05-01 to 2014-04-30	88,300	USD	365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	0	USD	366
2015-05-01 to 2015-12-31	0	USD	245
2014-05-01 to 2015-04-30	70,304	USD	365
2013-05-01 to 2014-04-30	62,189	USD	365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	764,735	USD	366
2015-05-01 to 2015-12-31	359,041	USD	245
2014-05-01 to 2015-04-30	784,012	USD	365
2013-05-01 to 2014-04-30	-718,436	USD	365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2016-01-01 to 2016-12-31	0	USD	366
2015-05-01 to 2015-12-31	0	USD	245
2014-05-01 to 2015-04-30	0	USD	365
2013-05-01 to 2014-04-30	-99,204	USD	365

Inspect the source

Entity: TENAX THERAPEUTICS, INC. / CIK 0000034956
Captured: 2026-09-19T14:46:45.117Z
SEC response SHA-256: 3f4f90f5f823d316ffb20bc63506ae090888657f5ff1cb9568439e153f028cf5

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000034956.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))